CNS
Beyond's analysis on CNS
- — LG CNS expands pharmaceutical manufacturing automation footprint at CPHI Milan 2026
- — Headlands Research marks 50 years of contributing to Alzheimer's CNS clinical trials, underscoring its long-standing role in neuropharmacology development
- — Insilico Medicine and CMS expand AI‑driven R&D partnership to accelerate CNS disease therapeutics
Recent news mentioning CNS
- — Cerenome Secures In-Network Agreement with Florida Blue for CNSide® CSF Tumor Cell Enumeration and Molecular Profile Tests
- — LG CNS presenta soluciones de fabricación AX específicas para el sector farmacéutico
- — LG CNS präsentiert auf der weltweit größten Pharma- und Biotech-Messe eine branchenspezifische Fertigungs-AX-Lösung für die Pharmaindustrie
- — LG CNS présente sa solution AX dédiée à la fabrication pharmaceutique lors du plus grand salon mondial dédié à l'industrie pharmaceutique et aux biotechnologies
- — LG CNS Showcases Pharma-Specific Manufacturing AX at World's Largest Pharma-Biotech Show
- — Cerenome Launches CNSide® CSF Molecular Profile Tests
- — Headlands Research - Summit Portland Celebrates 50 Years of Advancing Alzheimer's and CNS Clinical Research
- — Cerenome Expects $1.55 Million in CNSide® Third Quarter Gross Billings
- — Cerenome to Hold CNSide® Business Update Call on September 30, 2026
- — Cerenome Secures In-Network Agreement with Blue Cross Blue Shield of Michigan, Expanding CNSide® Contracted Coverage to Approximately 158 Million Covered Lives
- — Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division
- — Pasqal and LG CNS partner to power Next-generation AI Data centers with quantum computing